February 22, 2018 / 6:34 AM / 3 months ago

BRIEF-Novartis AG Says Ultibro Breezhaler Improved Cardiac Function In COPD Patients With Lung Hyperinflation‍​

Feb 22 (Reuters) - Novartis Ag:

* SAYS TREATMENT WITH NOVARTIS’ ULTIBRO BREEZHALER IMPROVED CARDIAC FUNCTION IN COPD PATIENTS WITH LUNG HYPERINFLATION‍​ Further company coverage: (Reporting by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below